Aminodiol HIV Protease Inhibitors. Synthesis And Structure−Activity Relationships Of P<sub>1</sub>/P<sub>1</sub>‘ Compounds: Correlation between Lipophilicity and Cytotoxicity
作者:Ping Chen、Peter T. W. Cheng、Masud Alam、Barbara D. Beyer、Gregory S. Bisacchi、Tamara Dejneka、Adelaide J. Evans、Jill A. Greytok、Mark A. Hermsmeier、W. Griffith Humphreys、Glenn A. Jacobs、Octavian Kocy、Pin-Fang Lin、Karen A. Lis、Michael A. Marella、Denis E. Ryono、Amy K. Sheaffer、Steven H. Spergel、Chong-qing Sun、Joseph A. Tino、Gregory Vite、Richard J. Colonno、Robert Zahler、Joel C. Barrish
DOI:10.1021/jm950717a
日期:1996.1.1
A series of novel aminodiol inhibitors of HIV protease based on the lead compound 1 with structural modifications at P1' were synthesized in order to reduce the cytotoxicity of 1. We have observed a high degree of correlation between the lipophilicity and cytotoxicity of this series of inhibitors. It was found that appropriate substitution at the para position of the P1' phenyl group of 1 resulted
为了减少1的细胞毒性,合成了一系列基于P1'结构修饰的先导化合物1的HIV蛋白酶的新型氨基二醇抑制剂。我们已经观察到该系列抑制剂的亲脂性和细胞毒性之间存在高度相关性。 。发现在P1'苯基基团对位1处的适当取代导致鉴定出等价的(对酶和细胞培养均如此)化合物(10l,10m,10n和15c),这些化合物具有明显降低的细胞毒性。